U.S. Transportation Stock News

NasdaqGM:OCS
NasdaqGM:OCSPharmaceuticals

Oculis FDA Milestone And DME Data Spotlight Eye Pipeline And Valuation

Oculis Holding secured a formal Special Protocol Assessment from the FDA for its pivotal Phase 3 PIONEER-1 trial of Privosegtor in optic neuritis. The FDA agreement confirms that the PIONEER-1 trial design is adequate to support a potential future NDA submission. In parallel, new findings from the DME AWARE study support further development of OCS-01 eye drops for diabetic macular edema. These updates arrive with NasdaqGM:OCS trading at $31.09, with the stock up 13.1% over the past week and...
NYSE:RPM
NYSE:RPMChemicals

A Look At RPM International (RPM) Valuation After Better Than Expected Q3 2026 Results And Upbeat Guidance

RPM International (RPM) drew fresh attention after reporting third quarter fiscal 2026 earnings and sales that exceeded expectations, alongside guidance regarding sales and adjusted EBIT. See our latest analysis for RPM International. The share price has eased back recently, with a 1 month share price return of 4.84% but a 90 day share price return decline of 13.30%, while the 1 year total shareholder return decline of 6.79% contrasts with a 3 year total shareholder return of 32.76%. This...
NasdaqGM:PAHC
NasdaqGM:PAHCPharmaceuticals

Is It Time To Reassess Phibro Animal Health (PAHC) After The Recent Share Price Pullback

Investors may be wondering if Phibro Animal Health at around US$43.16 is still offering value after a strong run, or if the easy gains are behind it. The stock has pulled back 18.8% over the last week and 22.5% over the last month, yet it still shows a 15.7% gain year to date and a 96.6% return over the past year. These sharp moves are drawing attention back to what is already priced into Phibro Animal Health and how much of its story is reflected in the current share price. Ongoing interest...
NYSE:APLE
NYSE:APLEHotel and Resort REITs

Assessing Apple Hospitality REIT (APLE) Valuation After Its Recent Share Price Momentum

Recent performance puts Apple Hospitality REIT in focus Apple Hospitality REIT (APLE) has drawn fresh attention after a one-month return of about 19% and a gain of roughly 14% over the past three months, prompting investors to reassess the hotel-focused REIT’s recent momentum. See our latest analysis for Apple Hospitality REIT. At a share price of $13.89, Apple Hospitality REIT’s recent 19.43% 1 month share price return and 15.17% year to date share price return contrast with a steadier 1...
NasdaqGM:ZLAB
NasdaqGM:ZLABBiotechs

Zai Lab Weighs New Pipeline Data And KarXT Launch Against Revenue Pressures

Zai Lab (NasdaqGM:ZLAB) reported new clinical data from its global oncology and immunology pipeline, including intracranial response data for zoci in small cell lung cancer. The company is preparing to launch KarXT in China for schizophrenia in the next quarter. Management highlighted these pipeline and launch updates while also flagging near term revenue pressure. Zai Lab focuses on developing and commercializing medicines in oncology and immunology, as well as central nervous system...
NasdaqGS:BRKR
NasdaqGS:BRKRLife Sciences

Is It Time To Reassess Bruker (BRKR) After Its Recent Share Price Jump?

If you are wondering whether Bruker stock is priced attractively or already reflects its prospects, the recent share moves make that question especially timely. The stock last closed at US$43.73, with returns of 19.1% over the past week and 19.3% over the past month, compared with an 8.5% gain over the past year and longer term returns over 3 and 5 years that have been negative. These shorter term gains come after a period where investors have been reassessing many life sciences and tools...
NasdaqGS:RXRX
NasdaqGS:RXRXBiotechs

A Look At Recursion Pharmaceuticals (RXRX) Valuation After Recent Clinical And Cost Management Updates

Recursion Pharmaceuticals (RXRX) is back in focus after a busy Q1 2026, with fresh clinical data for REC-1245, first patient dosing for REC-4539, and FDA engagement around REC-4881 following promising Phase 2 results. See our latest analysis for Recursion Pharmaceuticals. The clinical updates and Q1 results have come with pressure on the stock, with a 30 day share price return of 2.51% contrasting with a 1 year total shareholder return decline of 25.51%, which points to fading longer term...
NYSE:A
NYSE:ALife Sciences

Is Agilent Technologies (A) Fairly Priced After Mixed Returns And DCF Upside Signals?

Wondering if Agilent Technologies at US$118.65 is offering solid value or just fair pricing right now? This article breaks down what the current market price might be implying. The stock is up 2.7% over the last week and 4.2% over the last month, even though the year to date return stands at a 14.0% decline and the 1 year return is 10.0%. Taken together, these figures provide a mixed picture of sentiment and recent momentum. Recent coverage has focused on how Agilent Technologies fits into...
NYSE:WCN
NYSE:WCNCommercial Services

Is Waste Connections (WCN) Now Attractive After a 20.8% Share Price Slide?

For investors considering whether Waste Connections at around US$153.57 represents fair value or a potential opportunity, this article explains what the current price may indicate. The stock has come under recent pressure, with a 6.8% decline over the last week, a 6.4% decline over the last month, and a 20.8% decline over the last year. This comes despite 3 year and 5 year returns of 9.3% and 32.4% respectively. Recent coverage has examined how the stock's pullback compares with the broader...
NasdaqGS:DGII
NasdaqGS:DGIICommunications

Digi International Reshapes IoT Model As ARR Jumps 50%

Digi International acquired Jolt Software and Particle Industries, reshaping its Internet of Things (IoT) offering. The company reports that these deals, combined with organic growth, have lifted annual recurring revenue (ARR) by 50%. Management highlights strong cash flow as a key support for integrating these acquisitions into the existing business. Digi International (NasdaqGS:DGII) is drawing fresh attention as it leans harder into IoT platforms and recurring software revenue. The stock...
NYSE:BLDR
NYSE:BLDRBuilding

Is Builders FirstSource (BLDR) Now Fairly Priced After A Tough Year For The Stock?

If you are wondering whether Builders FirstSource at around US$79.41 is starting to look interesting again, the key question is how its current price compares with a fair estimate of value. The stock has inched up 0.4% over the last week and 0.6% over the last month, but that sits against a much tougher backdrop, with returns of a 24.1% decline year to date and a 28.5% decline over the past year. These moves come as the market continues to reassess building and construction related stocks,...
NYSE:MAIN
NYSE:MAINCapital Markets

Main Street Capital (MAIN) One Off Gain Skews High Margins And Challenges Earnings Decline Narrative

Main Street Capital (MAIN) has wrapped up FY 2025 with fourth quarter revenue of US$145.5 million and basic EPS of US$1.46. This sets the tone for a year in which trailing twelve month revenue reached US$566.4 million and EPS was US$5.52. Over recent periods, the company has reported quarterly revenue ranging between US$137.0 million and US$145.5 million, while basic EPS has moved between US$1.31 and US$1.46. Trailing net income for the year was US$493.4 million, as investors weigh those...
NasdaqGS:IREN
NasdaqGS:IRENSoftware

IREN (IREN) Is Up 24.9% After $3.4 Billion NVIDIA AI Cloud Deal - What's Changed

Earlier this week, IREN Limited announced it had signed a five-year AI infrastructure cloud services contract with NVIDIA worth about US$3.40 billion, under which IREN will supply managed GPU cloud services using Blackwell systems across roughly 60MW at its Childress, Texas data centers. Alongside this cloud deal, NVIDIA received a five-year right to buy up to 30 million IREN shares at US$70 each, tying IREN’s shift from Bitcoin mining toward large-scale AI infrastructure directly to a major...
NYSE:RVLV
NYSE:RVLVSpecialty Retail

Are Revolve Group’s (RVLV) Stronger Q1 Numbers Clarifying Its Long-Term Earnings Power Story?

In the first quarter ended March 31, 2026, Revolve Group, Inc. reported sales of US$342.88 million, net income of US$14.35 million, and diluted earnings per share from continuing operations of US$0.20, all higher than a year earlier. This past-quarter improvement in both revenue and profitability gives investors fresh data to reassess how Revolve’s growth investments may be translating into earnings power. With first-quarter revenue and net income both higher year over year, we’ll now...
NYSE:BALL
NYSE:BALLPackaging

Is It Time To Reassess Ball (BALL) After Recent Price Pullback?

Wondering if Ball at around US$58.41 is offering fair value or potential mispricing? This article breaks down what the current share price might be implying about the stock. The stock is up 9.5% year to date and 14.5% over the last year. However, there have been shorter term pullbacks, with a 4.4% decline over the past week and a 1.4% decline over the past month. Recent coverage has focused on Ball's position in materials and packaging, as investors reassess how companies in this space might...
NasdaqGS:HEPS
NasdaqGS:HEPSMultiline Retail

How D-Market’s Q1 2026 Revenue Surge and Wider Loss Will Impact D-Market Elektronik Hizmetler ve Ticaret (HEPS) Investors

D-Market Elektronik Hizmetler ve Ticaret A.S. recently released its first-quarter 2026 results, reporting sales of TRY 23,136.56 million compared with TRY 18,827.87 million a year earlier, alongside a net loss of TRY 991.97 million versus TRY 464.69 million previously. The combination of strong top-line expansion and a larger loss underlines how D-Market’s growth investments and cost structure are still weighing on profitability. Next, we’ll examine how this strong revenue growth but wider...
NYSEAM:GTE
NYSEAM:GTEOil and Gas

Gran Tierra Energy (GTE) Posts US$193 Million TTM Loss Testing Turnaround Narratives

Gran Tierra Energy (NYSEAM:GTE) has wrapped up FY 2025 with fourth quarter revenue of US$132.6 million and a basic EPS loss of US$3.99, alongside a full year trailing revenue base of US$596.7 million and a trailing basic EPS loss of US$5.45. Over recent periods, the company has seen quarterly revenue range from US$147.0 million to US$170.5 million. Basic EPS has moved between a small profit of US$0.04 in late 2024 and losses including US$0.54 in the first quarter of 2025, setting up an...
NYSE:MTDR
NYSE:MTDROil and Gas

Is It Time To Revisit Matador Resources (MTDR) After The Recent Share Price Pullback?

Wondering if Matador Resources at around US$55.57 is offering solid value or asking too much for its growth story? This article walks through the key signals to help you judge whether the current price looks appealing. The stock has pulled back with a 12.4% decline over the last 7 days and a 13.8% decline over the last 30 days, even though the year to date return sits at 28.2% and the 1 year return at 35.3%. Recent coverage has focused on Matador Resources in the context of broader energy...
NYSE:BCO
NYSE:BCOCommercial Services

What Brink's (BCO)'s Q1 Profit Dip and AMS Shift Means For Shareholders

In the past week, The Brink's Company reported first-quarter 2026 results, with revenue rising to US$1,375.1 million from US$1,246.7 million a year earlier, while net income declined to US$32.1 million from US$51.6 million and diluted EPS from continuing operations eased to US$0.77 from US$1.18. Alongside reaffirmed focus on higher-margin ATM Managed Services and Digital Retail Solutions, Brink's issued second-quarter 2026 revenue guidance of US$1,370 million to US$1,430 million and...
NasdaqCM:NODK
NasdaqCM:NODKInsurance

NI Holdings (NODK) Combined Ratio Near 110% Reinforces Bearish Underwriting Narratives

NI Holdings (NODK) just closed out FY 2025 with Q4 total revenue of US$61.0 million and a basic EPS loss of US$0.15, alongside a net loss of US$3.2 million, putting margins firmly under pressure. Over recent quarters, total revenue has moved from US$73.9 million in Q4 2024 to US$71.4 million in Q1 2025 and US$76.1 million in Q2 2025 before landing at US$61.0 million in Q4 2025, while EPS has swung from a profit of US$0.47 in Q4 2024 to a loss of US$0.57 in Q2 2025 and a loss of US$0.15 in the...
NYSE:CCI
NYSE:CCISpecialized REITs

Does Crown Castle’s US$8.4 Billion Fiber Exit and Debt Reset Change The Bull Case For CCI?

In early May 2026, Crown Castle completed the US$8.40 billion sale of its Fiber and Small Cell businesses, raised full-year 2026 net income guidance to US$690 million–US$970 million, and put in place a new US$4.50 billion unsecured revolving credit facility maturing in 2031. By refocusing on towers, using asset-sale proceeds to cut more than US$7.00 billion of debt, fund a US$1.00 billion buyback, and launch a cost-cutting plan, Crown Castle is reshaping its balance sheet and earnings...
NYSE:WFC
NYSE:WFCBanks

Wells Fargo (WFC) Valuation Check As Recent Returns Raise Questions On Upside Potential

What recent returns signal for Wells Fargo (WFC) shareholders Wells Fargo (WFC) has seen its stock post a 1.6% decline over the past day, with losses of 3.7% over the past week, about 3.2% over the past month, and 15.8% over the past 3 months. See our latest analysis for Wells Fargo. At a share price of $79.16, Wells Fargo’s short term share price momentum has cooled. A 16.9% year to date share price decline contrasts with a 10.9% 1 year total shareholder return and a 122.6% 3 year total...
NYSE:TKR
NYSE:TKRMachinery

Raised Outlook And Dividend Hike Could Be A Game Changer For Timken (TKR)

The Timken Company recently reported first-quarter 2026 results showing year-over-year growth in sales to US$1,231.3 million and net income to US$98.2 million, while also announcing an increased quarterly dividend of US$0.36 per share payable on May 29, 2026. Alongside these results, Timken raised its full-year 2026 earnings and revenue guidance, highlighting progress in reshaping its portfolio and expanding the Industrial Motion business through acquisitions such as Bijur Delimon. We’ll now...
NasdaqCM:SBET
NasdaqCM:SBETHospitality

Sharplink (SBET) Q4 Net Income Loss Of US$734.5 Million Reinforces Bearish Narratives

Sharplink (NasdaqCM:SBET) has wrapped up FY 2025 with Q4 revenue of US$15.8 million and basic EPS of a US$3.51 loss, against a backdrop of trailing twelve month revenue of US$28.1 million and basic EPS of a US$7.37 loss. Over recent quarters, the company has seen quarterly revenue move from US$0.7 million in Q1 2025 to US$10.8 million in Q3 2025 and then US$15.8 million in Q4 2025, while EPS shifted from a US$1.73 loss in Q1 to EPS of US$0.70 in Q3 and back to a US$3.51 loss in Q4. This puts...